Quick read
Fair Value Engine
Decision-focused synthesis of expected stock prices combining relative peer multiples and intrinsic models.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot
RH stock price vs MNRO: inconclusive
Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Price gap
N/A
Coverage
Medium · 60%
Free account · revisit it from your workspace
Quick read
Decision-focused synthesis of expected stock prices combining relative peer multiples and intrinsic models.
Latest stored price
Metric-by-metric
Filter, sort, and scan where each company leads, where gaps are small, and where comparisons are not meaningful.
| Metric | RH | MNRO | Spread |
|---|---|---|---|
Revenue growth (YoY) FY 2025 -> FY 2026 | 8.1% | -3.2% | RH leads by 354.9% Higher Revenue growth |
Gross margin | 44.1% | 35.0% | RH leads by 25.8% Higher Gross margin |
EBITDA margin | 22.0% | 4.6% | RH leads by 374.8% Higher EBITDA margin |
EV/Revenue | N/M | N/M | Insufficient data No additional context |
P/E | N/M | N/M | Not comparable Not comparable |
Net debt / EBITDA | -0.2 | 4.2 | RH leads by 105.8% Lower Net debt / EBITDA |
Statements
Core income statement and balance sheet metrics aligned to the reporting windows.
| Metric | RH | Delta vs MNRO | MNRO |
|---|---|---|---|
| Revenue | $3.44B | 197.2% higher | $1.16B |
| Gross profit | $1.52B | 274.0% higher | $405.26M |
| Operating income | $387.27M | 1833.5% higher | $20.03M |
| EBITDA | $755.50M | 1311.4% higher | $53.53M |
| Net income | $124.79M | 5642.6% higher | $2.17M |
| EPS | 6.3 | 20933.3% higher | 0.0 |
| Revenue growth | 8.1% | 354.9% higher | -3.2% |
| Gross margin | 44.1% | 25.8% higher | 35.0% |
| Operating margin | 11.3% | 550.5% higher | 1.7% |
| EBITDA margin | 22.0% | 374.8% higher | 4.6% |
| Net margin | 3.6% | 1832.0% higher | 0.2% |
Trendline
Track multi-year revenue, earnings, and margin direction before underwriting a rerating.
Price framework
Market cap + debt - cash, shown for the current pair and benchmark median context.
Price framework
Baseline discounted cash flow model estimating total intrinsic firm value first, then bridging to an implied stock price per share.
Risk control
Financial health checks to separate durable balance sheets from potential value traps.
Comparable set
Place both companies in context relative to a wider comparable universe.
LLM-powered Synthesis
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
RH screens materially better than MNRO on growth, profitability, and leverage, and the valuation gap looks supported by much stronger operating economics despite some balance-sheet quality concerns.
If you believe RH can sustain its 8.1% growth and 11.3% operating margin without major balance-sheet deterioration, then RH remains the better relative-value choice because its P/E and EV/EBITDA are far more reasonable than MNRO's despite a weaker-than-ideal Z-Score.
RH trades at a much stronger operating profile than MNRO, yet MNRO-implied valuation output is highly distorted by MNRO's extreme P/E of 408.3x and weak profitability. On the provided ranges, RH's current price of $165.52 sits within its historical band and below the DCF range, while MNRO-implied valuation range is extremely wide.
Supporting Metrics